The latest trading day saw Crocs (CROX) settling at $102.64, representing a -0.64% change from its previous close.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 3.73% of ...

January 23, 2025) - The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Delaware on behalf of those who acquired ...

Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of common stock of Crocs, Inc. between November 3, 2022 and October 28, ...

The law firm of Robbins Geller Rudman & Dowd LLP announces that the Crocs class action lawsuit seeks to represent purchasers or acquirers of Crocs, Inc. common stock between November 3, 2022 and ...

NEW YORK, NY / ACCESS Newswire / January 23, 2025 / If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a ...

Law Offices of Howard G. Smith announces an investigation on behalf of Crocs, Inc. ("Crocs" or the "Company") (NASDAQ: CROX) investors concerning the Company's possible violations of federal ...

The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Crocs, Inc. (NASDAQ: CROX) ("Crocs" or the "Company") on ...

The owner of Dr. Scholl's, Caleres (NYSE:CAL) is a footwear company offering a range of styles. Caleres reported revenues of $740.9 million, down 2.8% year on year, falling short of analysts’ ...

Williams Trading analyst adjusted the firm's stance on shares of Crocs (NASDAQ:CROX), downgrading the stock rating from Buy to Hold and revising the price target down to $112 from the previous $126.